Clinical Trials Logo

Abortion, Threatened clinical trials

View clinical trials related to Abortion, Threatened.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06393426 Completed - Infertility Clinical Trials

The Constitution and Efficacy of Chinese Medicine of Infertility Male, Female, and Pregnant Female

Start date: January 1, 2023
Phase:
Study type: Observational

The project aims to conduct a retrospective study to assess the impact of Traditional Chinese Medicine (TCM) on improving pregnancy rates and preventing miscarriages. It will include patients with infertility issues or a history of miscarriage. The study will analyze demographic and physiological data, TCM constitution, basal body temperature, reproductive history for females, and semen analysis for males, to determine the effectiveness of TCM care in enhancing fertility outcomes.

NCT ID: NCT06011057 Completed - Clinical trials for Threatened Miscarriage

Evaluation of Serum Levels of C Reactive Protein (CRP) and Its Correlation With Fetal Ultrasound Parameters in the Prediction of Threatened Miscarriage in the First Trimester

Start date: July 1, 2022
Phase:
Study type: Observational

The goal of this observational study is to evaluate and compare in pregnant women with threatened miscarriage in the first trimester. The main questions it aims to answer are: What is the correlation between serum C reactive protein (CRP) levels and fetal ultrasound parameters in predicting threatened miscarriage? How accurate are serum C reactive protein (CRP) levels versus ultrasound in predicting pregnancy loss in threatened miscarriage? Participants will have blood tests to measure C reactive protein (CRP) levels and fetal ultrasound exams to assess parameters like crown-rump length. Researchers will compare serum C reactive protein (CRP) levels and fetal ultrasound findings to see if either or both can accurately predict pregnancy loss in women with first trimester threatened miscarriage.

NCT ID: NCT04788108 Completed - Threatened Abortion Clinical Trials

Oral Progesterone for Prevention of Miscarriage in Threatened Abortion

Start date: August 1, 2021
Phase: Phase 4
Study type: Interventional

This study evaluates the effectiveness of oral dydrogesterone in preventing miscarriage in threatened abortion. Half of participants will receive oral dydrogesterone, while the other half will receive oral placebo.

NCT ID: NCT04217200 Completed - Clinical trials for Miscarriage Threatening

Pregnancy Dating Test - The Fall of hPL in Urine Over Time

Start date: February 19, 2020
Phase:
Study type: Observational

Earlier studies describe the half-life of hPL in serum as being ninety minutes and that the hormone is excreted unchanged in urine; consequently, there is real potential to use the fall in hormone levels in urine to monitor bleeding in pregnancy, the outcome of natural and artificial abortions or placental health. This study will focus on the fall of hPL following delivery by Caesarean section when women have a urinary catheter in place and sampling urine is simple to achieve.

NCT ID: NCT03930212 Completed - Clinical trials for Progesterone Resistance

Progesterone Supplementation in Threatened Abortion

Prothreat
Start date: January 1, 2018
Phase: Phase 4
Study type: Interventional

To decide whether progesterone supplementation in threatened abortion is a sound practice.

NCT ID: NCT03548701 Completed - Clinical trials for Pregnancy Trimester, First

Thromboelastometry Prediction Utility for Risk of Abortion

TEMPURA
Start date: June 4, 2018
Phase:
Study type: Observational

This study will use thromboelastometry in ED patients with vaginal bleeding, as well as healthy pregnant controls, to determine if abnormal results are associated with the presence of vaginal bleeding as well as later complications during pregnancy.

NCT ID: NCT03358940 Completed - Clinical trials for Threatened Miscarriage

Assessment of Non-medical Use of Misoprostol in Case of Miscarriage or Threatened Miscarriage.

MISO
Start date: March 29, 2016
Phase: N/A
Study type: Interventional

Non-medical used of misoprostol for abortion is a growing concern in Guadeloupe. Such situation is reasonable for countries in which abortion is not easy to obtain or prohibited. However regarding the risk of complications, it is less understandable in region like Guadeloupe where legal abortion with medical assistance is accessible for all and free. The aim of the study is to investigate on the amount of misoprostol taken by women in Guadeloupe, by doing an analytical measurement. The aim is to evaluate batter this practice in Guadeloupe, when the main objective of the study is to detect the presence or the absence of misoprostol in the urine sample of the woman coming at hospital for threatened miscarriage or miscarriage complications. Moreover, these abortions can be more important than spontaneous miscarriage.

NCT ID: NCT03320213 Completed - Clinical trials for Threatened Miscarriage in First Trimester

Value of CA125 and Yolk Sac Morphology in Prediction of Pregnancy Outcome in Threatened Miscarriage

Start date: October 1, 2016
Phase: N/A
Study type: Observational

evaluation of serum CA125 level and yolk sac morphology in women with threatened miscarriage is very important to predict pregnancy outcome

NCT ID: NCT03309735 Completed - Clinical trials for Threatened Miscarriage

Non-interventional Study of Therapy for Threatened Miscarriage

Start date: October 16, 2017
Phase: N/A
Study type: Observational

Study the efficacy and safety of therapy for threatened miscarriage with medicinal products Utrogestan (micronized progesterone), 200 mg capsules (Besins Healthcare SA, Belgium), and Duphaston (Dydrogesterone), 10 mg coated tablets (Abbott Healthcare Products B.V., the Netherlands)

NCT ID: NCT02686112 Completed - Threatened Abortion Clinical Trials

Pregnancy Outcome in Woman With Threatened Abortion

POTA
Start date: January 2007
Phase: N/A
Study type: Observational

The study aims to quantify the relations between first & second trimester bleeding and maternal & neonatal morbidity. Additionally, the study will help in assessing the risk for abortions in women with threatened abortions and the risk factors for threatened abortion.